Fox Chase Cancer Center – Temple Health Surgeon Robert G. Uzzo, MD, FACS, Elected to the American Association of Genitourinary Surgeons

PHILADELPHIA (August 14, 2015) – A nationally recognized leader in urologic oncology, Robert G. Uzzo, MD, FACS, chair of the Department of Surgery and co-leader of Genitourinary Cancer Treatment team at Fox Chase Cancer Center-Temple Health, has been elected to the American Association of Genitourinary Surgeons.

With only about 75 American urologist members, The American Association of Genitourinary Surgeons is one of the most prestigious societies of academic and clinical urologists in the world.

As an attending surgeon of Urologic Oncology and professor at Fox Chase, Uzzo’s clinical interests focus on treatment for kidney, prostate, testicular and bladder cancers, with an emphasis on minimally invasive surgical techniques to treat urinary diversions, in particular.

Uzzo serves as the G. Willing “Wing” Pepper Chair in Cancer Research. He is also a fellow of the American College of Surgeons and is the national urology principle investigator for the Eastern Cooperative Oncology Group trial to evaluate targeted therapies for kidney cancers.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text